Stocks and Investing Stocks and Investing
Mon, February 26, 2018
Fri, February 23, 2018

Andrew Peters Maintained (BMRN) at Strong Buy with Increased Target to $124 on, Feb 23rd, 2018


Published on 2024-10-26 03:17:44 -
  Print publication without navigation


Andrew Peters of Deutsche Bank, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $119 to $124 on, Feb 23rd, 2018.

Andrew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Cory Kasimov of "JP Morgan" Maintained at Buy with Decreased Target to $129 on, Wednesday, January 24th, 2018
  • Liana Moussatos of "Wedbush" Upgraded from Hold to Buy on, Thursday, December 14th, 2017